Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) are involved in the destruction of pancreatic β cells and the development of insulin‐dependent diabetes mellitus (IDDM). However, the cellular mechanism responsible for β cell death is still unclear. We hypothesize that activation of NFκB by ROS is the key cellular signal in initiating a cascade of events leading to β cell death. Thus, enhancement of pancreatic GSH, a known antioxidant and key regulator of NF‐κB, should protect against IDDM. Weanling CD1 mice ( n =5) were injected with alloxan (50 mg/kg i.v.) to induce IDDM. Using EPR spin trapping techniques, we demonstrated that alloxan generated ROS in the pancreas 15 min after administration. Activation of NFκB in pancreatic nuclear extracts was observed 30 min after alloxan injection, as assessed by an electrophoretic mobility shift assay. Fasting blood glucose levels were monitored for 14 days. Supplementation with N‐acetylcysteine (NAC, 500 mg/kg), a GSH precursor, inhibited alloxan‐induced NFκB activation and reduced hyperglycemia. Thus, NFκB activation by ROS may initiate a sequence of events leading to IDDM. Inhibition of NF‐κB activation by NAC attenuated the severity of IDDM. This research will contribute to the understanding of the etiology of IDDM and may lead to the development of better strategies for disease prevention.—Ho, E., Chen, G., Bray, T. M. Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice. FASEB J . 13, 1845–1854 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 1×
“proinflammatory cytokines such as IL-2 (19), IL-6 (20), tumor necrosis factor a (21), and inducible nitric oxide synthase (iNOS) (22).”
BackgroundCollins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542214 · Cited by 1,718
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267 · cited 1×
“GSH also protects sulfhydryl groups from oxidation (26, 27).”
BackgroundOberley, L. W. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90036-6 · Cited by 1,105
Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Cited by
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
β-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897
Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00053-0 · Cited by 427
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
Wagener, F. A. D. T. G., Eggert, A., Boerman, O. C., Oyen, W. J. G., Verhofstad, A., Abraham, N. G., Adema, G., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Blood · doi:10.1182/blood.v98.6.1802 · Cited by 421
De Flora, S., Izzotti, A., D'Agostini, F., & Balansky, R. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.999 · Cited by 351
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315
The potential biological mechanisms of arsenic-induced diabetes mellitus
Tseng, C.-H. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.009 · Cited by 296
Mitochondrial functional state in clonal pancreatic β-cells exposed to free fatty acids.
Koshkin, V., Wang, X., Scherer, P. E., Chan, C. B., & Wheeler, M. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209709200 · Cited by 121
NF-κB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection
Lim, J. W., Kim, H., & Kim, K. H. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00592-5 · Cited by 74
Metadata
- Authors
- Ho, E., Chen, G., & Bray, T. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 13
- Issue
- 13
- Pages
- 1845-1854
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1936765564
- Cited by
- 128
- References
- 5
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.